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Abstract Exposure of biological cells to a sufficiently
strong external electric field results in increased perme-
ability of cell membranes, referred to as ‘‘electroporation.’’
Since all types of cells (animal, plant and microorganism)
can be effectively electroporated, electroporation is con-
sidered to be a universal method and a platform technol-
ogy. Electroporation has become a widely used technology
applicable to, e.g., cancer treatment, gene transfection,
food and biomass processing and microbial inactivation.
However, despite significant progress in electroporation-
based applications, there is a lack of coordination and
interdisciplinary exchange of knowledge between
researchers from different scientific domains. Thus, critical
mass for new major breakthroughs is missing. This is why
we decided to establish cooperation between research
groups working in different fields of electroporation.
Cooperation in Science and Technology (COST), which
funds networking and capacity-building activities, presents
a perfect framework for such scientific cooperation. This
COST action aims at (1) providing necessary steps toward
EU cooperation of science and technology to foster basic
understanding of electroporation; (2) improving commu-
nication between research groups, resulting in streamlining
European research and development activities; and (3)
enabling development of new and further development of
existing electroporation-based applications by integrating
multidisciplinary research teams, as well as providing
comprehensive training for early-stage researchers. Results
of this COST action will provide multiple societal, scien-
tific and technological benefits from improving existing
electroporation-based applications to adding new ones in
the fields of medicine, biotechnology and environmental
preservation.
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Introduction
Exposure of biological cells to a sufficiently strong external
electric field results in transiently or permanently increased
permeability of cell membranes, referred to as ‘‘electro-
poration.’’ Since all types of cells (animal, plant and
microorganism) can be effectively electroporated, without
addition of viral or chemical compounds, electroporation is
considered to be a universal method and a platform tech-
nology. As such, it presents a common link to research areas
in medicine, biotechnology, the environment and energy.
The efforts needed to develop these applications and to
address diverse aspects of electroporation (biological,
chemical, physical, material science, modeling) are thus
multidisciplinary. Therefore, to be efficient and successful,
strong links need to be established between physicians,
engineers and scientists working in different scientific
domains. Electroporation is currently used in food and bio-
mass processing (Martin-Belloso and Sobrino-Lopez 2011;
Toepfl et al. 2007; Sack et al. 2010) and as a local treatment
of cancer (Sersa et al. 2012; Testori et al. 2012). Preservation
of food by electroporation was demonstrated to maintain
color, flavor and levels of antioxidants, while destroying
microorganisms. Recently, extraction of intracellular com-
ponents from plants (Sack et al. 2010) as well as cryopres-
ervation using electroporation (Phoon et al. 2008) have been
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demonstrated. Electroporation is also used for local cancer
treatment of skin metastases, a treatment called ‘‘electr-
ochemotherapy’’ (Marty et al. 2006). Since 2006, more than
4,000 patients in Europe have been successfully treated. The
objective response rate of all tumors that were treated in
these clinical trials was 78 %, with complete response of
52 % (Sersa et al. 2012). Clinical centers are already
working on three innovative systems for drug delivery to the
colorectal system, the brain, bone and liver metastases
(Soden et al. 2007; Edhemovic et al. 2011; Mahmood and
Gehl 2011; Agerholm-Larsen et al. 2011; Fini et al. 2010).
However, for treatment of deep-seated tumor nodules, fur-
ther technological developments are needed (Pavliha et al.
2012). Electroporation has shown potential in pretreatment
of sludge and other substrates, leading to increased biogas
production. Other applications, such as water treatment
(Rieder et al. 2008; Gusbeth et al. 2009), extraction of oil
from algae and of sugar from sugar beets (Loginova et al.
2011), gene therapy (Andre et al. 2008), DNA vaccination
(Vandermeulen et al. 2009), cell fusion for systemic cancer
treatment and human monoclonal antibody production
(Usaj et al. 2010) are just a few of the foreseeable new
applications.
Despite significant progress and increased use of elec-
troporation-based applications, as well as the existence of a
large number of nationally funded research projects, there is
a lack of coordination and interdisciplinary exchange of
knowledge between researchers from different scientific
domains. Thus, critical mass in the form of human resources,
knowledge from different domains and research facilities for
major breakthroughs is often missing. Therefore, Coopera-
tion in Science and Technology (COST) Action TD1104 has
been prepared, which will provide the necessary steps
toward cooperation in science and technology to foster basic
understanding of electroporation and to enable further
development of new and existing electroporation-based
applications through integrating multidisciplinary research
teams, as well as provide comprehensive training for stu-
dents and early-stage researchers.
Classical EU-funded projects (e.g., EU FP, ERC, ESF,
EUREKA) mainly support research and development, either
basic or specific application-oriented. In contrast, COST
funds networking and capacity-building activities, thereby
representing a perfect framework for interdisciplinary
international collaboration in electroporation research,
which is at its current stage characterized by a relatively high
level of national (54 %) and private (21 %) funding. Coor-
dination of research in this action will at least partially
address some of the global challenges (according to the
Millennium Project, http://www.unmillenniumproject.org)
associated with science and technology, health issues,
long-term perspective, clean water and energy. Concrete
societal, scientific and technological benefits from the action
will arise in medicine (e.g., cancer treatment), biotechnology
(e.g., extraction from algae and other cell cultures,
improvement of industrial processes), environment preser-
vation (e.g., wastewater treatment, biogas production,
energy harvest from biomass) and food processing (e.g.,
extending shelf life of food, development of novel foods,
obtaining new ingredients).
About COST
COST was the first and is thus the oldest European network to
coordinate nationally funded research activities. COST
today covers 35 European member countries and is orga-
nized in nine scientific domains (for more details, see
http://www.cost.esf.org/about_cost). The main goal of
COST is to strengthen Europe in research through the sup-
port of cooperation and interaction between researchers. It
has in all these years grown largely from being a European
networking mechanism to being a wider, even worldwide,
cooperation framework. COST provides funds for coordi-
nation of research through COST actions, such as this one on
electroporation, while research remains funded on a national
level. COST actions are thus networking activities based on
predominantly nationally funded research projects on a
research topic that is of interest to at least five COST coun-
tries. There is a great emphasis on gender balance and
inclusion of young scientists. It also allows all interested
scientists from countries who sign the Memorandum of
Understanding (MoU, http://w3.cost.eu/fileadmin/domain_
files/BMBS/Action_TD1104/mou/TD1104-e.pdf) to join
the activities even after the start of the action.
The process of getting a specific COST action running
involves several steps. Based on a call, which is announced
twice per year, a researcher (the proposer was the author of
this article) on behalf of other researchers interested in a
topic submits a proposal for a COST action on a specific
topic from one of eight domains. If the proposal spans
multiple domains (like electroporation), then it is considered
a transdomain proposal and is evaluated as such. In the call
where the COST action ‘‘European network for develop-
ment of electroporation-based technologies and treatments’’
was submitted more than 90 proposals were received. After
the first evaluation, 11 proposers were asked to submit a full
proposal. After the second evaluation, five proposers were
invited to a hearing in front of the representatives of the
domain committees, after which three proposals were
selected for funding, for a success rate of little more than
3 %. The COST action on electroporation was submitted as
a transdomain action spanning different domains from bio-
medicine and molecular biosciences; food and agriculture;
information and communication technologies; material,
physics and nanosciences; and earth systems science and
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environmental management (ESSEM) to chemistry and
molecular sciences and technologies—thus a truly multi-
disciplinary, i.e., transdomain, COST action.
The networking activities within the COST action
include scientific and administrative meetings, short-term
scientific missions and organization of training schools.
Meetings can be organized in the form of a management
committee (i.e., administrative meeting), as a workshop on
a specific topic or as a conference. Funding is available for
the travel and subsistence costs of participants and for
partial coverage of the organizing costs of the meeting.
Short-term scientific missions are exchange visits of up to
3 months, aiming at strengthening collaboration between
researchers from different countries. Emphasis is on sup-
porting young researchers to learn new methods and per-
form experiments and measurements with equipment not
available at their home institution. Training schools are
intended for dissemination of research activities of the
COST action and have to provide intensive training for
young scientists in one of the laboratories but are also
intended for retraining as a part of life-long learning. Funds
are also available for dissemination of research results and
publication through regular scientific publishing channels,
such as peer-review journals, workshop and conference
proceedings and books, but also general-information leaf-
lets and brochures.
Reasons for the Action
Despite significant progress and increased use of electro-
poration-based applications, there is a lack of coordination
and interdisciplinary exchange of knowledge between
researchers from different scientific domains. Furthermore,
research and development of electroporation, even if fun-
ded within the EU program, is currently fragmented as it is
very often only ‘‘a service’’ in developing new applica-
tions—critical mass is thus missing. In order to obtain the
most from this platform technology and to avoid the same
research being replicated and funded more than once, it is
important to establish cooperation between research groups
from different domains. This is why it is necessary to
establish a coordination of research and network. The main
reason for this action is to enable cross-fertilization of
different areas that will allow exchange of experience and
knowledge. This will facilitate collaboration of different
specialists from engineering, physics, chemistry, biology
and medicine, thus providing a multidisciplinary approach
and critical mass for further improvement of existing and
development of new electroporation-based applications in
medicine, biotechnology, energy harvest from biomass and
the food industry.
Immediate and future benefits of the action:
– New knowledge, closing the gap between basic
research and applications
– Improving communication and avoiding duplication of
research efforts
– New and improved medical treatments (cancer treat-
ment, DNA vaccination, gene therapy)
– Safer and healthier food
– Savings in natural resources, development of energy-
efficient processes
– Opening new markets and creating new jobs
Envisaged electroporation based applications developed
within the action:
– New approaches in gene therapy for cancer treatment
and DNA vaccination for the medical device industry
– In food processing, extraction of valuable ingredients,
development of novel foods and improvement of
industrial food processes in terms of food safety and
food quality
– Microbial inactivation and biomass preprocessing in
wastewater treatment, biogas production and energy
production
Planning and Preparing the Proposal
Experts working on electroporation and electroporation-
based applications from different domains have been in
contact, working occasionally on developing treatment or
processing protocols but usually only on a national level
and only exceptionally internationally within EU FP pro-
jects. Considerable efforts have been made in the past few
years to bring together experts working with electropora-
tion in different areas such as food processing, cancer
treatment, pulsed power electronics and energy efficiency.
However, the success was limited. Experts were meeting at
conferences that were specialized, e.g., in cancer treatment
in general, in food quality and processing or in bioelec-
trochemistry; but none of them gave the opportunity to
focus on electroporation as a technology platform. Few
experts in the field made an attempt to bridge the gap
between different disciplines, but funding has been
obtained predominantly on the national level, which
potentially leads to funding duplication, poor coordination
of research and difficulties in exploiting the results.
Establishing a new professional organization dedicated
to the promotion of electroporation and electroporation-
based applications through organization of dedicated con-
ferences did not seem to be adequate at this stage of
development and at this level of collaboration. Therefore,
the COST action seems a perfect way to help the electro-
poration community to develop stronger links, exchange
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experience and bring together forces through establishing a
communication platform including regular meetings.
During the COST action proposal an extensive ques-
tionnaire was prepared in order to collect relevant infor-
mation regarding research groups and their funding. The
questionnaire was divided into seven sections:
1. Introduction—Questionnaire for a new COST action
2. Personal and academic information
3. Scientific expertise
4. Facts and figures of laboratory/department
5. Participation in COST actions and other international
cooperation
6. Expected results and benefits of the COST action
7. Additional information
This allowed us not only to prepare a high-quality pro-
posal but also to collect data on existing projects on
national, international and EU levels (Fig. 1a). The col-
lected data will serve as a reference level for future
research activities in the field of electroporation, against
which the success of this COST action will be measured
through the years of the action and at the end of the action.
A total of 73 experts from 25 countries participated in
the preparation of this proposal. According to the data
collected through the questionnaire, in the last 3 years
these experts worked on a total of 229 projects related to
electroporation, 152 of which were funded on a national
level, with 26 EU projects and 51 other international pro-
jects. The funding of participating research groups comes
predominantly from national (54 %), private (21 %) and
EU (10 %) sources (Fig. 1b).
According to the responses to the questionnaire, it was
established that 293 researchers and 115 PhD students
are currently working in COST country laboratories. In
addition to 56 research groups from 19 COST countries,
13 research groups with 56 researchers were from
countries with reciprocal agreements (Argentina,
Australia and New Zealand) and non-COST countries
(Russian Federation, Ukraine and United States), and
they also participated actively in the preparation of the
action (see Fig. 2 for participant structure). In these
research groups, 152 national and 51 international
research projects in the field of electroporation were
funded in the last 3 years. The groups also participated
in 26 EU FP projects in the last 3 years. This alone
provides the COST action with great potential for
coordination of these projects, thus providing better use
of resources, avoiding duplication of research and
allowing synergistic effects to take place.
The number of countries (19 COST and 6 non-COST
countries) that have actively participated in the prepara-
tion of the proposal clearly demonstrates the extent of
existing research and the need for coordination of this
research, which is predominantly funded on a national
level (54 %). Starting the COST action will allow also
‘‘smaller’’ groups that are working ‘‘alone’’ or are just
starting their research on a national level to join the
network. Until the kick-off meeting that took place on
April 10, 2012, in Brussels already 21 COST countries
had signed the Memorandum of Understanding and had
nominated national representatives.
Fig. 1 Number of projects on electroporation by type (a) and by
sources of funding (b) conducted by project proposers in the last
3 years
Fig. 2 Number of individual researchers and their representation by
sex and years in research
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Work Plan of the Project
Improving existing and developing new applications of
electroporation will be the topics of the research. Coordi-
nation of national and international projects will allow
collaborations not only between teams working in specific
fields of electroporation but also among partners from
different disciplines by using multidisciplinary approaches.
In particular, focus will be given to linking theoretical
efforts (e.g., analytical and numerical modeling of elec-
troporation) with experimental results to develop basic
knowledge of this phenomenon, which will be incorporated
into electroporation-based applications. Modeling efforts
on different levels—from the molecular level (molecular
dynamics simulations) to the cell and tissue level (finite
element modeling)—will be linked vertically and validated
with experimental results.
The work plan of the action consists thus of investi-
gating the basic mechanisms of electroporation and opti-
mizing protocols in different electroporation-based
applications, with special emphasis on food and biomass
processing, medical applications and sustainable energy
production (Fig. 3). Optimized protocols will allow tech-
nology development and transfer. The most important
research tasks coordinated by the action are briefly
described below.
1. Establishment of a close collaboration between
researchers in biology, chemistry, physics, mathemat-
ics, informatics and engineering to enhance our
understanding of electroporation and its associated
processes. This will start immediately after approval of
the action and will cover the first 3 years of the
cooperative program. Emphasis will be on modeling
the cell membrane with a goal of identifying the
underlying processes of membrane electroporation and
the associated phenomena (membrane destabilization,
cytoskeleton reorganization, transmembrane pathways,
etc.). Theoretical and modeling results will be com-
pared to experimental data.
2. Optimizing electroporation protocols for industrial
applications (e.g., food and biomass processing,
microbial inactivation). Conditions used in these
applications so far have only been determined empir-
ically, while the latest developments, such as intracel-
lular manipulation by nanosecond pulses, have not
been implemented yet. Based on recent studies on a
cellular level and basic research, processing conditions
for industrial applications will be optimized with
respect to low energy consumption. The knowledge
about the impact of processing conditions on electro-
poration efficacy will be reviewed, taking into account
specific industrial requirements (large-scale process-
ing, high throughput, environmental and economic
issues). General and application-oriented electropora-
tion protocols for food and biomass processing will be
gathered in a database. This will allow simple param-
eter selection for nonexperts and industrial end-users
and provide an easy-to-access knowledge base for
regulatory bodies.
3. Development of equipment design guidelines. Based
on electroporation protocols, the guidelines for design
of electroporation equipment (generators, electrode
Fig. 3 Diagram illustrating the
research processes and
knowledge transfer within the
action, emphasizing the process
of translating basic research into
applications. The working
groups (WGs) facilitate all
stages of the process
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systems, microchambers) will be elaborated with the
aim of achieving optimal treatment homogeneity, food
safety and hygienic design. In addition, a database of
applications already investigated and/or transferred
into industry will be generated. The available scientific
literature will be screened and information will be
collected on equipment suppliers (e.g., product type,
type of equipment, processing parameters). The data-
base, accessible to COST partners via a Web site, will
allow the selection of suitable, commercially viable
application areas in food and biomass processing and
the identification of new application fields.
4. Process monitoring. In the food industry, typically
hazard analysis and critical control points concepts
have to be followed to ensure food safety, where at
critical points processing conditions are recorded. For
electroporation, such protocols and suitable sensors
still have to be developed. The identification of
suitable monitoring techniques will be a key require-
ment for a broader application. Electrochemical reac-
tions and electrode erosion should be minimized with
regard to food safety. The impact of pulse wave shape
and frequencies as well as other pulse characteristics
and material-related effects will have to be determined
to develop optimal equipment and select optimal
processing conditions.
5. Development of electrochemotherapy (ECT) for can-
cer treatment. The development of electrodes for use in
internal organs, identification and testing of new
cancer drugs suitable for ECT and expansion of pulse
parameters to increase versatility of ECT are chal-
lenges that still need to be addressed and that require
future efforts. Clinical centers are already working on
three innovative systems for drug and gene delivery to
the colorectal system, the brain, bone and liver
metastases. Several centers have worked with drugs
other than conventional chemotherapeutic agents, and
expansion of the spectrum of such drugs would be
advantageous. The extension of attainable pulse
parameter ranges should increase the flexibility of
electroporation used in clinics in achieving both
reversible electroporation (as used for drug delivery)
and irreversible electroporation (with the aim of
causing cell death by electroporation alone).
6. Expansion of delivery technology for large molecules,
with a focus on end products such as DNA vaccines.
Use of electroporation to transfer nucleic acids to
various tissues (e.g., skeletal muscle, tumors, skin,
liver) has benefited from the electrodes, generators and
knowledge accumulated in the development of ECT
protocols. In vivo, combinations of electroporating and
electrophoretic pulses have been shown to be highly
efficient, and clinical studies have demonstrated their
safety compared to classical viral methods for gene
therapy. The results of the clinical trials must now be
promoted, and the researchers should dedicate their
efforts to finding optimal protocols, developing ade-
quate electrodes and generators, etc. The first clinical
trials of gene electrotransfer (EGT) either have
recently finished or are in progress. The range of
applications of EGT is broad, and particularly prom-
ising are its applications in the treatment of cancer and
infectious diseases. Development of nonviral EGT is a
collective task, and the COST action will impact its
emergence by gathering scientists with different
expertise.
7. Identification of new effects of interaction of short
electric pulses with biological matter and their possible
applications. In particular, emphasis will be placed on
the use of pulses with extremely short duration and
high voltage. Recently, experimental evidence for
growth stimulation of plants and fungi after treatment
with pulses of nanosecond duration and sublethal
amplitude was found, which promises applications in
biomass production and conditioning. Within this task,
further basic research demands will be identified.
8. Identification of synergetic process combinations. A
combination of thermal and electroporation treatments
has been shown to increase the microbial inactivation
performance of electroporation-based treatment. In
case of wastewater disinfection, the inactivation rate
of the combined process was also higher than the sum
of the rates of the single processes. Possibilities of
synergetic process combinations for other applications
will be investigated with regard to saving processing
energy and simplifying existing processes.
Organization and Implementation of the Project
The research work in the COST action will be conducted
by partners and financed predominantly through various
research agencies and grants, while COST will provide the
necessary coordination. The action is coordinated by the
management committee (MC, Fig. 4). The MC supervises
and coordinates implementation of the action. According to
the rules of procedure for the MC, the chair and vice chair
of the action were appointed at the kick-off meeting by the
MC. The MC also established working groups (WGs)
according to the scientific plan and appointed their leaders.
The MC will meet once a year to set priorities, plan
meetings and distribute funds to WG programs. The MC
will summarize the WGs results and produce action
reports, which will be posted on a dedicated Web site
(www.electroporation.net).
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Steering of the action will be further ensured by the
steering committee, to which the MC appointed three
experienced researchers from different WGs and at least
one representative of potential users, e.g., an industry
representative. A core group, composed of the chair, vice
chair, WG leaders and short-term scientific missions
(STSM) coordinator, will further ensure effective and
continuous steering for the action by maintaining regular
periodic contacts by means of conference calls, videocon-
ferences and meetings every 4 months or more frequently
when deemed necessary. The STSM coordinator will put
emphasis on the effective use of STSM as an instrument of
collaboration and training, with priority given to early-
stage researchers, who will be encouraged to also apply for
COST conference grants.
Five WGs have been established following the scientific
plan: WG 1, Basic Mechanisms of Electroporation and
Modeling; WG 2, Food Processing and Pharmaceuticals;
WG 3, Medical Applications; WG 4, Sustainable Environ-
mental Applications and Biomass Processing; and WG 5,
Technology Development and Transfer. Specific objectives
of each of these WG will be as follows
WG 1 Basic Mechanisms of Electroporation and Modeling
to obtain in-depth knowledge of the biological, physical and
chemical mechanisms underlying electroporation
WG 2 Food Processing and Pharmaceuticals to gain
knowledge on process–product interactions in food and
pharmaceutical applications involving electroporation
and combine it with the latest findings in other appli-
cation areas to improve equipment and process design
WG 3 Medical Applications to disseminate present
clinical applications, develop new applications and
standardize clinical protocols
WG 4 Sustainable Environmental Applications and
Biomass Processing to improve the economic and
technological efficiency of environmental and biomass
applications of electroporation
WG 5 Technology Development and Transfer to
exchange technical knowledge on development of safe
and reliable electroporation systems for industrial appli-
cations and clinical use.
Each WG will have a leader appointed by the MC who
will be responsible for organization, program preparation
and reporting to the MC. The organization of work and
coordination in these five WGs will allow members to
focus on specific scientific questions and research, facili-
tating coordination and preparation of annual programs and
activities of the action, which will be prepared by the WGs
and submitted for approval to the MC.
Expected Results
Electroporation requires multidisciplinary research, inte-
grating efforts of experts from different domains, from
basic research to applications and from life sciences to
engineering sciences. As experience from the past shows,
interdisciplinary research, i.e., collaboration of a mixed
group of experts from different fields, allows us to address
even the most important world challenges, such as health
Fig. 4 COST Action TD1104
management structure diagram
identifying the key management
entities and their interactions.
TDP transdomain proposal, FA
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issues, clean water, science and technology and energy
sources.
Electroporation has a direct impact on health (cancer
treatment, DNA vaccination) and environmental (water
disinfection) issues. Huge benefits may be expected from
applications in food preservation that increases nutritional
value but also in reducing the waste from agricultural
resources by improving extraction efficiency and reducing
energy demand. Positive effects on the environment can
also be expected in biomass processing (e.g., economic
algae processing for use as an energy source) and waste-
water treatment.
It is exactly through the mechanisms of networking and
coordination activities provided within the COST TD1104
Action that synergies are expected, offering the possibility
to improve the existing and develop new electroporation-
based applications. These synergies will result in new spin-
off project proposals, new processes and products achieved
by means of international collaboration, multidisciplinary
approach and reaching the critical mass in human resources
and equipment. For example, in food processing optimi-
zation toward highest energy efficiency and low operation
and investment costs is required to allow for further
development of technology. Making use of the extensive
amount of research performed in the medical sector, this
COST action will allow a knowledge transfer and a sig-
nificant step toward a broader use of electroporation in
other industry sectors including the food processing
industry and pharmacy.
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